NCT06335992

Brief Summary

The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identify (or validate) biomarkers mirroring systemic processes such as reduced inflammation and ameliorating the epithelial barrier in these patients. These events may additionally act as potential targets for interventions. Objectives (i) Evaluate biomarkers for regenerative processes, matrix turnover, stem cell activity and inflammatory patterns in lung tissue biopsies, blood- and urine samples correlated to vital lung parameters and physical capacity, before and after attending an exercise-training program. (ii) Study the effects of exercise training on the pulmonary ventilation/perfusion ratio and quality of life. (iii) Evaluate the relation between pathophysiology in the lung evaluated by CT scan, and systemic response measured by muscle biopsies and biomarkers in blood/urine. (iv) Investigate in vitro cell behaviour and remodelling/regenerative processes altered in COPD patients upon exercise training (aim 1).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Sep 2022

Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

March 7, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 28, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

3.3 years

First QC Date

March 7, 2024

Last Update Submit

August 13, 2025

Conditions

Keywords

Chronic obstructive pulmonary diseaseExerciseRegeneration

Outcome Measures

Primary Outcomes (1)

  • Pulmonary Function

    FEV1 (Forced Expiratory volume in one second)

    Baseline, post intervention at 12 wks

Secondary Outcomes (5)

  • Physical capacity

    Baseline, post intervention at 12 wks

  • Inflammation markers

    Baseline, post intervention at 12 wks

  • Level of emphysema

    Baseline, post intervention at 12 wks

  • Maximal physical capacity ( Wmax)

    Baseline, post intervention at 12 wks

  • COPD Assessment Test (CAT)

    Baseline, post intervention at 12 wks

Study Arms (1)

Exercise

EXPERIMENTAL

The exercise training protocol to be used in this study: Supervised exercise training (aerobic- and muscle strengthening exercise): 2 times a week for 12 weeks. * Aerobic exercise with ergometer cycling for 30 min, at moderate intensity (60% Wpeak) individually adjusted to level 4-6 on the Borg category ratio-10 scale. * Muscle strengthening exercise will consist of 8-12 strength exercises of the major upper and lower body muscle groups. Each exercise includes three sets with 8-12 repetitions. Exercise training at home: once a week for 12 weeks.

Other: Exercise regime

Interventions

Exercise

Exercise

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator
  • Optimal medical treatment according to GOLD and the Swedish National Guidelines
  • Absence of other significant diseases that could contribute to physical exercise limitation
  • Non-smoking since at least one year
  • Free from exacerbations (last 4 weeks)
  • BMI = 18- 35

You may not qualify if:

  • Regular participation in adjusted/specially designed exercise sessions
  • Unstable cardiovascular or pulmonary disease
  • Smoking
  • Any other criteria that at the discretion of the investigator prevent the study subject from participating in an exercise-training program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Lund University

Lund, Sweden

RECRUITING

Uppsala University

Uppsala, Sweden

RECRUITING

Related Publications (1)

  • Larsson C, Elowsson L, Tufvesson E, Cederberg A, Ohrneman H, Falcones B, Karlsson L, Akbarshahi H, Ankerst J, Bjermer L, Palm A, Londahl J, Malinovschi A, Janson C, Emtner M, Westergen-Thorsson G. Activation of regenerative pathways by exercise intervention in subjects with chronic obstructive pulmonary disease - a study protocol. Respir Res. 2025 Dec 12. doi: 10.1186/s12931-025-03443-y. Online ahead of print.

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 28, 2024

Study Start

September 1, 2022

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations